1. Academic Validation
  2. Association of Vemurafenib and Pipobroman Enhances BRAF-CRAF Dimerization in Squamous Cell Carcinoma

Association of Vemurafenib and Pipobroman Enhances BRAF-CRAF Dimerization in Squamous Cell Carcinoma

  • J Invest Dermatol. 2016 Jun;136(6):1302-1305. doi: 10.1016/j.jid.2015.12.047.
Charles Cassius 1 Cécile Pages 2 Jennifer Roux 2 Raphael Lhote 2 Romain Lavocat 3 Delphine Réa 4 Martine Bagot 2 Samia Mourah 5 Maxime Battistella 6 Céleste Lebbé 7 Nicolas Dumaz 5
Affiliations

Affiliations

  • 1 Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France. Electronic address: charles.cassius@gmail.com.
  • 2 Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
  • 3 Department of Plastic Surgery, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
  • 4 Department of Hematology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
  • 5 INSERM U976 and Univ Paris Diderot, Sorbonne Paris Cité, Paris, France.
  • 6 Department of Pathology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
  • 7 Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France; INSERM U976 and Univ Paris Diderot, Sorbonne Paris Cité, Paris, France.
Figures
Products